A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite. (2020)
Attributed to:
Tropical Infectious Disease Consortium: Expanding and Accelerating Product Development
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-020-19981-6
PubMed Identifier: 33323937
Publication URI: http://europepmc.org/abstract/MED/33323937
Type: Journal Article/Review
Volume: 11
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723